Anti-HYOU1 antibody (950-999) {FITC} (STJ501379)

SKU:
STJ501379-100

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: ELISA/IHC/IP/WB
Reactivity: Human/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-HYOU1 (950-999) is suitable for use in ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: FITC
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.5 µg/µl
Dilution Range: WB: 1:500
ELISA: 1:10, 000
IP: 1:200
IHC: 1:50-1:100
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: HYOU1
Gene ID: 10525
Uniprot ID: HYOU1_HUMAN
Immunogen Region: 950-999
Immunogen: Synthetic peptide taken within amino acid region 950-999 on human Hypoxia up regulated 1.
Tissue Specificity Highly expressed in tissues that contain well-developed endoplasmic reticulum and synthesize large amounts of secretory proteins. Highly expressed in liver and pancreas and lower expression in brain and kidney. Also expressed in macrophages within aortic atherosclerotic plaques, and in breast cancers.
Function Has a pivotal role in cytoprotective cellular mechanisms triggered by oxygen deprivation. May play a role as a molecular chaperone and participate in protein folding.
Protein Name Hypoxia Up-Regulated Protein 1
150 Kda Oxygen-Regulated Protein
Orp-150
170 Kda Glucose-Regulated Protein
Grp-170
Database Links Reactome: R-HSA-3000484
Reactome: R-HSA-381038
Cellular Localisation Endoplasmic Reticulum Lumen
Alternative Antibody Names Anti-Hypoxia Up-Regulated Protein 1 antibody
Anti-150 Kda Oxygen-Regulated Protein antibody
Anti-Orp-150 antibody
Anti-170 Kda Glucose-Regulated Protein antibody
Anti-Grp-170 antibody
Anti-HYOU1 antibody
Anti-GRP170 antibody
Anti-ORP150 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance